Lawsuit Overview
An investor, who currently holds shares of Osiris Therapeutics, Inc. (NASDAQ: OSIR), filed a lawsuit against the takeover of Osiris Therapeutics, Inc. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ: OSIR stockholders by agreeing to sell Osiris Therapeutics, Inc. cheaply via an unfair process. On March 12, 2019, Osiris Therapeutics, Inc. (NAS...
You must register (for free) or login to view the entire case.